In a colon cancer study TRAIL expressing ASCs induced by M1 macrophages decrease the level of CD133+ cancer stem cells and decreased the number of M2 macrophages, thus boosting the anti-tumor efficacy of TRAIL [205]. Here, TNFSF10 is linked to neoplasm.